ResourceDrug Discovery & Development
Building stronger AI foundations for drug discovery
12 May 2026This resource explores how the success of artificial intelligence in drug discovery depends on the quality, structure, and governance of underlying data. It highlights how fragmented, incomplete, or biased datasets can limit AI performance, and outlines approaches to improve data readiness through FAIR principles, standardization, and collaborative frameworks such as federated learning.
Explore how platforms like Signals One™ enable researchers to unify and structure data across workflows, supporting more reliable AI‑driven insights and accelerating decision‑making in drug development.
Related products
Request Quote for All Products
Signals One™
Revvity SignalsMake your innovations a reality with the first unified, cloud-native SaaS R&D solution that streamlines scientific complexity and promotes collaboration.
Links
Tags
Artificial Intelligence / Machine LearningArtificial intelligence (AI) and machine learning (ML) are transformative technologies used to analyze complex data, identify patterns, and make data-driven predictions across diverse scientific fields. Automate the analysis of large or complex data sets using AI algorithms and leverage machine learning models to improve diagnostics, accelerate drug discovery, and refine experimental design. Discover the best AI/ML software, platforms, and analytical tools in our peer-reviewed product directory: compare features, read customer reviews, and request pricing directly from manufacturers.Data ManagementBioinformaticsBioinformatics uses computational models and methodologies to study biological processes and to understand biological data.